A Ferrant
Overview
Explore the profile of A Ferrant including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
235
Citations
2336
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Klastersky J, Ferrant A, Longeval E, Hendrikx A, Lachapelle J, Van Acker K, et al.
Acta Clin Belg
. 2016 Jul;
33(1):69-72.
PMID: 27369110
No abstract available.
2.
El-Najjar I, Boumendil A, Luan J, Bouabdallah R, Thomson K, Mohty M, et al.
Ann Oncol
. 2014 Sep;
25(11):2224-2229.
PMID: 25193988
Background: The aim of this study was to investigate the impact of the high-dose regimen on the outcome of patients with follicular lymphoma (FL) having had autologous stem-cell transplantation (ASCT)...
3.
Girardot M, Pecquet C, Chachoua I, van Hees J, Guibert S, Ferrant A, et al.
Oncogene
. 2014 Apr;
34(10):1323-32.
PMID: 24681953
STAT (Signal Transducer and Activator of Transcription) transcription factors are constitutively activated in most hematopoietic cancers. We previously identified a target gene, LPP/miR-28 (LIM domain containing preferred translocation partner in...
4.
Kelaidi C, Park S, Sapena R, Beyne-Rauzy O, Coiteux V, Vey N, et al.
Leukemia
. 2013 Feb;
27(6):1283-90.
PMID: 23370672
A large proportion of lower-risk myelodysplastic syndromes (MDS) respond to erythropoiesis-stimulating agents (ESA), but most responses are transient. We updated a previously reported cohort of lower-risk MDS patients treated with...
5.
Van Der Linden P, Lambermont M, Dierick A, Hubner R, Benoit Y, De Backer D, et al.
Acta Clin Belg
. 2012 Aug;
67(3):201-8.
PMID: 22897069
The following recommendations, which aim at improving the clinical diagnosis ofTRALI and the laboratory investigations that can support it, were drawn up by a working group of the Superior Health...
6.
Ljungman P, Locasciulli A, de Soria V, Bekassy A, Brinch L, Espigado I, et al.
Bone Marrow Transplant
. 2011 Dec;
47(9):1217-21.
PMID: 22158388
This prospective study was initiated in 1993 with the aim to study late effects and responses to antiviral therapy in a cohort of hepatitis C virus (HCV)-infected patients. A total...
7.
Jantunen E, Canals C, Attal M, Thomson K, Milpied N, Buzyn A, et al.
Ann Oncol
. 2011 Apr;
23(1):166-171.
PMID: 21467125
Background: Limited experience is available on the feasibility and efficacy of autologous stem-cell transplantation (ASCT) in patients with mantle cell lymphoma (MCL) beyond 65 years. Design And Methods: We analysed...
8.
Medves S, Duhoux F, Ferrant A, Toffalini F, Ameye G, Libouton J, et al.
Leukemia
. 2010 Feb;
24(5):1052-5.
PMID: 20164854
No abstract available.
9.
Baele P, Muylle L, Noens L, Gulliksson H, Brands A, Isbister J, et al.
Acta Clin Belg
. 2009 Feb;
63(5):301-12.
PMID: 19186562
The following recommendations, which aim at standardising and rationalising clinical indications for the transfusion of red cells in Belgium, were drawn up by a working group of the Superior Health...
10.
De Backer D, Vandekerckhove B, Stanworth S, Williamson L, Hermans C, Van Der Linden P, et al.
Acta Clin Belg
. 2009 Jan;
63(6):381-90.
PMID: 19170354
Recommendations, which aim at standardising and rationalising clinical indications for the transfusion of fresh frozen plasma (FFP) in Belgium, were drawn up by a working group of the Superior Health...